Vanderbilt Research Trending

Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.

Kristin Archer, PhD, DPT, associate professor and vice chair of Orthopaedics and Rehabilitation, will serve as principal investigator at Vanderbilt University Medical Center (VUMC) for a clinical trial that is examining strategies for reducing opioid use among patients with chronic pain.

Vanderbilt psychologists have discovered that when you shift your attention from one place to another, your brain 'blinks'—or experiences momentary gaps in perception.

Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan.

Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world.

Vanderbilt scientists have taken an important step toward understanding the way in which injured cells trigger wound healing, an insight essential for improving treatments of all types of wounds.

Eleven Vanderbilt faculty members named to endowed chairs were recognized for their exemplary achievements during a celebration Sept. 6 at the Student Life Center.